Role of peptide YY(3–36) in the satiety produced by gastric delivery of macronutrients in rats
- 1 May 2013
- journal article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 304 (9) , E944-E950
Abstract
Peptide YY(3–36) [PYY(3–36)] is postulated to act as a hormonal signal from gut to brain to inhibit food intake. PYY(3–36) potently reduces food intake when administered systemically or into the brain. If action of endogenous PYY(3–36) is necessary for normal satiation to occur, then pharmacological blockade of its receptors should increase food intake. Here, we determined the effects of iv infusion of Y1, Y2, and Y5 receptor antagonists (BIBP 3226, BIIE 0246, CGP 71683) during the first 3 h of the dark period on food intake in non-food-deprived rats. Our results showed that 1) Y2 receptor blockade reversed the anorexic response to iv infusion of PYY(3–36) but did not increase food intake when administered alone; 2) Y1 and Y5 receptor antagonists neither attenuated PYY(3–36)-induced anorexia nor altered food intake when given alone; and 3) Y2 receptor blockade attenuated anorexic responses to gastric infusions of casein hydrolysate and long-chain triglycerides, but not maltodextrin. Previous work showed that Y2 antagonist BIIE 0246 does not penetrate the blood-brain barrier. Together, these results support the hypothesis that gut PYY(3–36) action at Y2 receptors peripheral to the blood brain barrier plays an essential role in mediating satiety responses to gastric delivery of protein and long-chain triglycerides, but not polysaccharide.Keywords
This publication has 49 references indexed in Scilit:
- Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3–36) on food intakeBrain Research, 2005
- The Role of the Vagal Nerve in Peripheral PYY3–36-Induced Feeding Reduction in RatsEndocrinology, 2005
- Flavor preferences conditioned by intragastric nutrient infusions in food restricted and free-feeding ratsPhysiology & Behavior, 2005
- Intravenous Infusion of Peptide YY(3–36) Potently Inhibits Food Intake in RatsEndocrinology, 2005
- Peptide YY(3–36) inhibits gastric emptying and produces acute reductions in food intake in rhesus monkeysAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2005
- Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptorNature Medicine, 1999
- Role of cholecystokinin in the anorexia produced by duodenal delivery of peptone in rats.American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 1999
- XVI. International Union of Pharmacology Recommendations for the Nomenclature of Neuropeptide Y, Peptide YY, and Pancreatic Polypeptide ReceptorsPharmacological Reviews, 1998
- Role of cholecystokinin in the anorexia produced by duodenal delivery of glucose in ratsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 1996
- Role of cholecystokinin in the anorexia produced by duodenal delivery of oleic acid in ratsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 1995